HomeBlog

Cannabis Research Buds Out in New Directions, Arthritis to Insomnia

Debra Kamin, This Week at UC San Diego News, October 10, 2019

With 33 states and the District of Columbia having legalized medical marijuana, it was inevitable that there would be much talk of its therapeutic benefits, real or imagined. But lost in the equally inevitable hype has been hard scientific proof.

For almost two decades, the Center for Medicinal Cannabis Research (CMCR) at UC San Diego has been conducting such research, for much of that time largely alone and often, given the controversial nature of the subject, with limited resources. But times are changing, and CMCR recently announced a first wave of five new grants worth a total of $3 million to explore the efficacy and safety of medical cannabis as a supplementary or alternative treatment for schizophrenia, rheumatoid arthritis, insomnia, alcohol dependence and anxiety linked to anorexia.

Read the article here

San Diego schools look to take mystery and misinformation out of medical marijuana

Jared Aarons, ABC 10News San Diego, September 10, 2019

Starting this fall, the Pacific College of Oriental Medicine is offering the first-ever certificate program specializing in medical marijuana.

The three-semester class promises to teach health care professionals the basics of medical cannabis, so they can begin to use it in their practice.

"We thought it was important for health care professionals to have objective information about medical marijuana," says school President Jack Miller.

Miller says part of the program's purpose is to help dispel some of the myths surrounding medical marijuana.

Read the article here

Marijuana Culture Has Arrived, But The Science Is Still Catching Up

Shalina Chatlani, KPBS, December 19, 2019

More people are buying marijuana since California legalized its retail sale two years ago. But the scientific research to show consumers the risks and benefits of marijuana use is just starting to accelerate.

Read the article and view the video here

Targets of Opportunity for Medicinal Cannabis Research with Dr. Igor Grant, CMCR UCSD

Karen Jagoda, Empowered Patient Podcast, November 19, 2019

Dr. Igor Grant, Director, Center for Medicinal Cannabis Research at the University of California San Diego talks about the need for basic science studies on new indications and promises of cannabinoids, potential medical effects of both THC and CBD, the uptick in funding for clinical studies, relative safety of cannabis compared to other drugs, and which diseases and chronic conditions are currently being effectively treated with some form of cannabis.

Listen to the podcast or download the transcript here

Pure CBD Won't Make You Fail a Drug Test, But…

Amy Norton, HealthDay, August 9, 2019

As the CBD craze sweeps the nation, some users may wonder whether the cannabis extract can make them fail a drug test. A preliminary study suggests the answer is "no" -- at least if the CBD is pure.

Researchers found that CBD, or cannabidiol, did not react with either of two commercially available tests used to screen for marijuana use. However, another cannabis compound -- cannabinol (CBN) -- did.

CBD and CBN are two of many chemicals found in cannabis plants. They differ from THC, the source of the marijuana "high." CBD is present in marijuana but more abundant in hemp -- cannabis plants that have little THC. CBN, meanwhile, is a THC derivative.

If you think CBD products are suddenly everywhere, you're right: There has been an explosion since last year, when Congress lifted a decades-old ban on growing hemp.

Read the article here

More Articles …

Page 20 of 23